Literature DB >> 12107278

Rig is a novel Ras-related protein and potential neural tumor suppressor.

Chad A Ellis1, Michele D Vos, Heather Howell, Teresa Vallecorsa, Daniel W Fults, Geoffrey J Clark.   

Abstract

The Ras superfamily consists of a large group of monomeric GTPases demonstrating homology to Ras oncoproteins. Although structurally similar, Ras-superfamily proteins are functionally diverse. Whereas some members exhibit oncogenic properties, others may serve as tumor suppressors. We have identified a novel Ras-related protein that suppresses cell growth and have designated it Rig (Ras-related inhibitor of cell growth). Overexpression of Rig inhibited Ras-mediated cellular transformation and activation of downstream signaling in NIH 3T3 cells. rig mRNA is expressed at high levels in normal cardiac and neural tissue. However, Rig protein expression is frequently lost or down-regulated in neural tumor-derived cell lines and primary human neural tumors. Moreover, expression of exogenous Rig in human astrocytoma cells suppressed growth. Rig has a C-terminal CAAX motif that codes for posttranslational modification by both farnesyl and geranylgeranyl isoprenoid lipids. Consequently, Rig may play a role in the cellular response to farnesyl transferase inhibitors. Rig bears 63% overall sequence homology to a recently described Ras-family member Noey2, a tumor suppressor in breast and ovarian tissue. Therefore, Rig and Noey2 may represent a new subfamily of Ras-like tumor suppressors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107278      PMCID: PMC125049          DOI: 10.1073/pnas.142193799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?

Authors:  A D Cox; C J Der
Journal:  Biochim Biophys Acta       Date:  1997-08-08

2.  Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system.

Authors:  T Watsuji; Y Okamoto; N Emi; Y Katsuoka; M Hagiwara
Journal:  Biochem Biophys Res Commun       Date:  1997-05-29       Impact factor: 3.575

Review 3.  Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic.

Authors:  J B Gibbs; A Oliff; N E Kohl
Journal:  Cell       Date:  1994-04-22       Impact factor: 41.582

4.  Biological assays for Ras transformation.

Authors:  G J Clark; A D Cox; S M Graham; C J Der
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation.

Authors:  G J Clark; M S Kinch; K Rogers-Graham; S M Sebti; A D Hamilton; C J Der
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

6.  Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.

Authors:  G C Prendergast; J P Davide; S J deSolms; E A Giuliani; S L Graham; J B Gibbs; A Oliff; N E Kohl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

Review 7.  Farnesyltransferase inhibitors and anti-Ras therapy.

Authors:  J B Gibbs; N E Kohl; K S Koblan; C A Omer; L Sepp-Lorenzino; N Rosen; N J Anthony; M W Conner; S J deSolms; T M Williams; S L Graham; G D Hartman; A Oliff
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice.

Authors:  N E Kohl; C A Omer; M W Conner; N J Anthony; J P Davide; S J deSolms; E A Giuliani; R P Gomez; S L Graham; K Hamilton
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

9.  Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.

Authors:  J K Westwick; A D Cox; C J Der; M H Cobb; M Hibi; M Karin; D A Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma.

Authors:  S R Ritland; V Ganju; R B Jenkins
Journal:  Genes Chromosomes Cancer       Date:  1995-04       Impact factor: 5.006

View more
  20 in total

Review 1.  Inhibition of Ras for cancer treatment: the search continues.

Authors:  Antonio T Baines; Dapeng Xu; Channing J Der
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

2.  Identification and characterization of RHEBL1, a novel member of Ras family, which activates transcriptional activities of NF-kappa B.

Authors:  Jian Yuan; Yuxi Shan; Xinya Chen; Wenwen Tang; Kuntian Luo; Jun Ni; Bo Wan; Long Yu
Journal:  Mol Biol Rep       Date:  2005-12       Impact factor: 2.316

3.  The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases.

Authors:  Desirée García-Torres; Carol A Fierke
Journal:  J Biol Chem       Date:  2019-06-13       Impact factor: 5.157

4.  Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.

Authors:  Howard Donninger; Nadia Allen; Adrianna Henson; Jennifer Pogue; Andrew Williams; Laura Gordon; Susannah Kassler; Thomas Dunwell; Farida Latif; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

5.  RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells.

Authors:  Margie N Sutton; Hailing Yang; Gilbert Y Huang; Caroline Fu; Michael Pontikos; Yan Wang; Weiqun Mao; Lan Pang; Maojie Yang; Jinsong Liu; Jan Parker-Thornburg; Zhen Lu; Robert C Bast
Journal:  Autophagy       Date:  2018-03-21       Impact factor: 16.016

6.  Di-Ras2 Protein Forms a Complex with SmgGDS Protein in Brain Cytosol in Order to Be in a Low Affinity State for Guanine Nucleotides.

Authors:  Yoshitaka Ogita; Sachiko Egami; Arisa Ebihara; Nami Ueda; Toshiaki Katada; Kenji Kontani
Journal:  J Biol Chem       Date:  2015-07-06       Impact factor: 5.157

7.  GTPase activity of Di-Ras proteins is stimulated by Rap1GAP proteins.

Authors:  Raphael Gasper; Begoña Sot; Alfred Wittinghofer
Journal:  Small GTPases       Date:  2010-11

8.  NORE1A tumor suppressor candidate modulates p21CIP1 via p53.

Authors:  Diego F Calvisi; Howard Donninger; Michele D Vos; Michael J Birrer; Laura Gordon; Virna Leaner; Geoffrey J Clark
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  Zebrafish diras1 Promoted Neurite Outgrowth in Neuro-2a Cells and Maintained Trigeminal Ganglion Neurons In Vivo via Rac1-Dependent Pathway.

Authors:  Chi-Wei Yeh; Li-Sung Hsu
Journal:  Mol Neurobiol       Date:  2015-12-03       Impact factor: 5.590

Review 10.  Human RAS superfamily proteins and related GTPases.

Authors:  John Colicelli
Journal:  Sci STKE       Date:  2004-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.